APOE genotype/expression has been linked to human neurocognitive and neuroinflammatory disorders (e.g., Alzheimer’s disease [94], Parkinson’s disease [95–97] multiple sclerosis [98] and HIV disease progression [99]). This evidence concerns the gene APOE and glycogen storage disease VI.